Smith & Marjanovic Law Announces Attorney Taylor Smith Listed Among "Ones to Watch for Civil Rights Advocacy in New Mexico" by Best Lawyers
Albuquerque, New Mexico--(Newsfile Corp. - June 14, 2025) - New Mexico personal injury firm Smith & Marjanovic Law proudly announces that co-owner and attorney Taylor Smith has been named to the Best Lawyers: Ones to Watch award list, recognizing outstanding early-career attorneys.
Smith & Marjanovic Law Announces Attorney Taylor Smith Listed Among "Ones to Watch for Civil Rights Advocacy in New Mexico" by Best Lawyers
To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8814/254872_dd6f566bf432e8a4_002full.jpg
The Best Lawyers Ones to Watch awards are given to the most successful up-and-coming attorneys who demonstrate the highest degree of expertise and professionalism across American private legal practices.
Best Lawyers follows a rigorous, peer-driven selection process, from nomination and eligibility checks to final publication, to identify America's top legal talent. Nominated by peers and reviewed by best-in-class advocates, attorneys selected for the Ones to Watch are open-minded, forward-thinking individuals trusted by communities, not just individuals and businesses.
Taylor Smith began his legal career in New Mexico with a three-year tenure as a lawyer at Garret & Smith starting in 2019. In 2022, he joined Rothstein Donatelli as a full-time Associate Attorney, where he further honed his litigation skills. A year later, he founded Smith & Associates, laying the groundwork for a strategic merger with Milos Marjanovic, an esteemed U.S. attorney and founder of Marjanovic Law LLC.
With a client-first mindset and a commitment to raising the bar of professional, quality legal service as a wrongful death lawyer Albuquerque, Taylor's adaptability helped him become one of the most trusted lawyers in New Mexico. His empathetic approach, combined with sharp legal instincts, has made a lasting impact on clients from all walks of life.
From working with industry-recognized professionals and well-established brands to running a private legal practice and eventually joining forces with Marjanovic to create Smith & Marjanovic Law, Taylor met the Best Lawyers' criteria by holding essential roles and positions across multiple legal firms. Taylor's path to a Best Lawyers nomination is marked by years of consistent performance, community trust, and professional integrity.
Another major contributing factor to Taylor's nomination for Best Lawyers Ones to Watch is the varied portfolio of its legal practice. Beyond handling various cases tied to slip and fall accidents, motorcycle crashes, civil litigation, birth injuries, and hospital negligence, the firm's practice areas stretch across pedestrian accidents, family disputes, contract breaches, and many others.
Taylor Smith's inclusion in the Best Lawyers Ones to Watch list marks a crucial milestone in his legal career, and a recognition of technical excellence and commitment to client advocacy that Smith & Marjanovic Law, LLC is built on.
Smith & Marjanovic Law Announces Attorney Taylor Smith Listed Among "Ones to Watch for Civil Rights Advocacy in New Mexico" by Best Lawyers
To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8814/254872_dd6f566bf432e8a4_003full.jpg
More information about Taylor Smith is available on the official website of his legal practice.
Contact Info:Name: Taylor SmithEmail: taylor@legalhelpnm.comOrganization: Smith & Marjanovic Law, LLCAddress: 6731 Academy Rd NE Suite B Albuquerque, NM 87109, United StatesPhone: 505-510-4440Website: https://legalhelpnm.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/254872
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
15 minutes ago
- Yahoo
The Open Group Launches The Open Group Open Digital Transformation™ Forum
Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO, July 28, 2025--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. "The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation," commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. "By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices." Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. "Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge," said Steve Nunn, President and CEO of The Open Group. "Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment." To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. View source version on Contacts Media contact Monika BoudovaHotwire for The Open GroupUKOpengroup@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15 minutes ago
- Yahoo
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio
